128 related articles for article (PubMed ID: 37472791)
21. Functioning ovarian tumors: direct and indirect findings at MR imaging.
Tanaka YO; Tsunoda H; Kitagawa Y; Ueno T; Yoshikawa H; Saida Y
Radiographics; 2004 Oct; 24 Suppl 1():S147-66. PubMed ID: 15486238
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of ovarian tumors in postmenopausal women by transvaginal sonography.
Osmers RG; Osmers M; von Maydell B; Wagner B; Kuhn W
Eur J Obstet Gynecol Reprod Biol; 1998 Mar; 77(1):81-8. PubMed ID: 9550206
[TBL] [Abstract][Full Text] [Related]
23. Reproductive Outcomes and Fertility Preservation Strategies in Women with Malignant Ovarian Germ Cell Tumors after Fertility Sparing Surgery.
Vasta FM; Dellino M; Bergamini A; Gargano G; Paradiso A; Loizzi V; Bocciolone L; Silvestris E; Petrone M; Cormio G; Mangili G
Biomedicines; 2020 Nov; 8(12):. PubMed ID: 33265938
[TBL] [Abstract][Full Text] [Related]
24. PAX2 and PAX8 reliably distinguishes ovarian serous tumors from mucinous tumors.
Wang M; Ma H; Pan Y; Xiao W; Li J; Yu J; He J
Appl Immunohistochem Mol Morphol; 2015 Apr; 23(4):280-7. PubMed ID: 24992169
[TBL] [Abstract][Full Text] [Related]
25. Role of Frozen Section in Surgical Management of Ovarian Neoplasm.
Palakkan S; Augestine T; Valsan MK; Vahab KPA; Nair LK
Gynecol Minim Invasive Ther; 2020; 9(1):13-17. PubMed ID: 32090007
[TBL] [Abstract][Full Text] [Related]
26. The diagnosis and pathological value of combined detection of HE4 and CA125 for patients with ovarian cancer.
Zheng LE; Qu JY; He F
Open Med (Wars); 2016; 11(1):125-132. PubMed ID: 28352780
[TBL] [Abstract][Full Text] [Related]
27. Insulin-Like Growth Factors (IGF) and IGF-Binding Proteins (IGFBP) in the Serum of Patients with Ovarian Tumors.
Gershtein ES; Isaeva ER; Kushlinsky DN; Korotkova EA; Ermilova VD; Laktionov KP; Adamyan LV
Bull Exp Biol Med; 2016 Apr; 160(6):814-6. PubMed ID: 27165066
[TBL] [Abstract][Full Text] [Related]
28. Survivin in ovary tumors.
Plewka D; Jakubiec-Bartnik B; Morek M; Bogunia E; Bienioszek M; Wolski H; Kotrych D; Dziekan K; Seremak-Mrozikiewicz A; Plewka A
Ginekol Pol; 2015 Jul; 86(7):525-30. PubMed ID: 26376531
[TBL] [Abstract][Full Text] [Related]
29. Canine ovarian tumors: an immunohistochemical study with HBME-1 antibody.
Banco B; Antuofermo E; Borzacchiello G; Cossu-Rocca P; Grieco V
J Vet Diagn Invest; 2011 Sep; 23(5):977-81. PubMed ID: 21908358
[TBL] [Abstract][Full Text] [Related]
30. Biochemical and immunohistochemical studies on carcinoembryonic antigen of ovarian mucinous and serous tumors.
Tohya T; Iwamasa T; Maeyama M
Gynecol Oncol; 1986 Mar; 23(3):291-303. PubMed ID: 3514390
[TBL] [Abstract][Full Text] [Related]
31. Epidemiology of borderline ovarian tumors.
Harlow BL; Weiss NS; Lofton S
J Natl Cancer Inst; 1987 Jan; 78(1):71-4. PubMed ID: 3025504
[TBL] [Abstract][Full Text] [Related]
32. Anatomic Distribution of Benign Ovarian Tumors in Perimenopausal and Postmenopausal Women.
Matalliotakis M; Matalliotaki C; Krithinakis K; Laliotis A; Kapetanios G; Tsakiridis I; Kalogiannidis I
Cureus; 2023 Jan; 15(1):e34059. PubMed ID: 36824539
[TBL] [Abstract][Full Text] [Related]
33. The accuracy of frozen section by tumor weight for ovarian epithelial neoplasms.
Puls L; Heidtman E; Hunter JE; Crane M; Stafford J
Gynecol Oncol; 1997 Oct; 67(1):16-9. PubMed ID: 9345350
[TBL] [Abstract][Full Text] [Related]
34. Androgen-Secreting Ovarian Tumors.
Macut D; Ilić D; Mitrović Jovanović A; Bjekić-Macut J
Front Horm Res; 2019; 53():100-107. PubMed ID: 31499493
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemistry: A diagnostic aid in differentiating primary epithelial ovarian tumors and tumors metastatic to the ovary.
Kriplani D; Patel MM
South Asian J Cancer; 2013 Oct; 2(4):254-8. PubMed ID: 24455652
[TBL] [Abstract][Full Text] [Related]
36. Appendiceal tumors in patients undergoing primary surgery for mucinous ovarian tumors in a tertiary hospital, in Southern Thailand.
Nanthamongkolkul K; Wattanapaisal P; Boonyapipat S; Suphasynth Y; Pichatechaiyoot A; Geater AF; Kayasut K; Peeyananjarassri K
Taiwan J Obstet Gynecol; 2022 Jul; 61(4):657-662. PubMed ID: 35779917
[TBL] [Abstract][Full Text] [Related]
37. Serous ovarian tumors: Immunohistochemical profiling as an aid to grading and understanding tumorigenesis.
Manu V; Hein TA; Boruah D; Srinivas V
Med J Armed Forces India; 2020 Jan; 76(1):30-36. PubMed ID: 32020965
[TBL] [Abstract][Full Text] [Related]
38. RETROSPECTIVE ANALYSIS OF BORDERLINE OVARIAN TUMORS: OUTCOMES AT A SINGLE CENTER.
Yilmaz E; Sahin N; Koleli I; Melekoglu R; Tanrikut E; Faydali S; Karaer A; Coskun EI
Acta Clin Croat; 2019 Mar; 58(1):29-36. PubMed ID: 31363322
[TBL] [Abstract][Full Text] [Related]
39. Genetic alterations of serous borderline tumors of the ovary compared to stage I serous ovarian carcinomas.
Osterberg L; Akeson M; Levan K; Partheen K; Zetterqvist BM; Brännström M; Horvath G
Cancer Genet Cytogenet; 2006 Jun; 167(2):103-8. PubMed ID: 16737908
[TBL] [Abstract][Full Text] [Related]
40. [Diagnosis of ovarian tumor by measuring tumor markers].
Fukatsu T; Nakashima N; Takeuchi J
Rinsho Byori; 1992 Feb; 40(2):133-8. PubMed ID: 1583785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
